Abstract： Objective： To observe the curative effect of Feire Kechuan Prescription combined with conventional therapy for community-acquired pneumonia with phlegm-heat obstructing the lung syndrome. Methods：A total of 123 cases of patients with community-acquired pneumonia with phlegmheat obstructing the lung syndrome were selected and divided into the control group and the combination group according to the random number table method，with 60 and 63 cases in each group，respectively. The control group was treated with conventional western medicine treatment，and the combination group was treated with Feire Kechuan Prescription combined with conventional western medicine therapy. Both groups were treated for 2 weeks. Clinical effects， imaging findings， the incidence of adverse reactions， and the remission time of clinical symptoms were observed in the two groups. Traditional Chinese medicine (TCM) syndrome scores and the levels of C-reactive protein (CRP)， procalcitonin (PCT)， and white blood cell count (WBC) in serum were compared between the two groups before and after treatment. Results： After treatment， the scores of main symptoms and secondary symptoms， and the total scores of TCM syndrome scores in the two groups were decreased when compared with those before treatment (P＜0.05)， the scores of main symptoms and secondary symptoms，and the total scores of TCM syndrome scores in the combination group were lower than those in the control group (P＜0.05). After treatment，the remission time of fever，cough，expectoration，and lung rales in the combination group was shorter than that in the control group，differences being significant (P＜0.05). After treatment，the levels of CRP，PCT and WBC in the two groups were decreased when compared with those before treatment (P＜0.05)， and the above three levels in the combination group were lower than those in the control group (P＜0.05). After treatment， the imaging absorption rate was 95.24% in the combination group and 81.67% in the control group， the difference being significant (P＜0.05). The total clinical effective rate was 95.24% in the combination group and 81.67% in the control group， the difference being significant (P＜0.05). The incidence of adverse reactions was 6.35% in the combination group and 8.33% in the control group，there being no significance in the difference (P＞0.05). Conclusion：In the treatment of community-acquired pneumonia with phlegmheat obstructing the lung syndrome， Feire Kechuan Prescription combined with modern medicine can significantly relieve symptoms and reduce the levels of inflammation，with obvious clinical effects and good safety.